<?xml version="1.0" encoding="UTF-8"?>
<ref id="B12-viruses-11-00365">
 <label>12.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>McGuigan</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Harris</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Daluge</surname>
    <given-names>S.M.</given-names>
   </name>
   <name>
    <surname>Gudmundsson</surname>
    <given-names>K.S.</given-names>
   </name>
   <name>
    <surname>McLean</surname>
    <given-names>E.W.</given-names>
   </name>
   <name>
    <surname>Burnette</surname>
    <given-names>T.C.</given-names>
   </name>
   <name>
    <surname>Marr</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Hazen</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Condreay</surname>
    <given-names>L.D.</given-names>
   </name>
   <name>
    <surname>Johnson</surname>
    <given-names>L.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency</article-title>
  <source>J. Med. Chem.</source>
  <year>2005</year>
  <volume>48</volume>
  <fpage>3504</fpage>
  <lpage>3515</lpage>
  <pub-id pub-id-type="doi">10.1021/jm0491400</pub-id>
  <?supplied-pmid 15887959?>
  <pub-id pub-id-type="pmid">15887959</pub-id>
 </element-citation>
</ref>
